November 29, 2011

BioCision standardizes clinical tissue sample shipments with Mayo Clinic-developed HistoMailer™

The HistoMailer, developed by the Mayo Clinic and refined for commercialization by BioCision, ensures simple, reliable transfer of tissue samples from the clinic to the laboratory.

MILL VALLEY, Calif.--(BUSINESS WIRE)--BioCision, LLC announced today the launch of a new product –the HistoMailer – for safely sending tissue blocks for laboratory analysis. The HistoMailer represents the first in a series of products designed to specifically address the need for safe, reliable transfer of samples between laboratories.

The HistoMailer was originally developed by technicians at Mayo Medical Laboratories, which receives approximately 30,000 specimens per day from hospitals across the country. According to Mayo Clinic Operations Coordinator Jeff Wills, “The HistoMailer provides end users with a value add when transporting lab specimens. The container is a full-circle tool, from start to finish and provides Mayo with the opportunity to become greener. Mayo’s Department of Laboratory Medicine and Pathology is currently using the technology, along with over one-thousand users across our client base.” Wills is also an inventor of the HistoMailer technology.

“Working with leading academic institutions to develop new tools and products is an important part of BioCision’s overall strategy to best serve biomedical researchers and clinicians,” said BioCision’s CEO Rolf Ehrhardt, MD, PhD.

BioCision specializes in benchtop products that ensure consistency, reproducibility and standardization of laboratory samples, with applications in drug discovery, and basic and clinical research. Users benefit from high sample reproducibility and consistency – experiment to experiment, lab to lab and research/clinical site to site.

Mayo Clinic and Mr. J. Willis have a financial interest in the technology referenced in this news release.

About BioCision

BioCision®, headquartered in Mill Valley, CA, is committed to the standardization of pre-analytical sample handling. They are the leading global developer of benchtop sample and assay management tools that enable collection, organization, protection, freezing, thawing, cooling and cryopreservation of samples in a consistent and highly reproducible manner. BioCision’s patent-pending line of benchtop tools include CoolRack®, CoolSink™ and CoolTray™ thermo-conductive tube and plate modules; CoolBox™ ice-free portable cooling/freezing containers; CoolCell® alcohol-free maintenance-free cell freezing containers; and accessories.


Hemai Parthasarathy, 202-415-3978


CoolCell® Controlled-rate cell freezing equivalent to CRFs

Contact BioCision:

About Us
Contact Us
Privacy Policy

© Copyright 2018, BioCision.
All rights reserved

BioCision is a life science research and development company that develops products and solutions for process standardization throughout the healthcare industry through the application of advanced thermal regulation principles and technologies. The intuitive design and interconnectivity of BioCision products enables researchers, clinicians and manufacturers to protect the integrity of temperature-sensitive therapeutics, biological samples, and biomaterials. By comprehensively addressing temperature stability, BioCision strives to improve the success of therapeutic discovery and development and enable effective care delivery.

Help 1-800-367-4887